• 1
    Collins AJ, Foley RN, Herzog C, et al. US Renal Data System 2010 Annual Data Report. Am J Kidney Dis 2011; 57 (1 Suppl 1): A8, e1526.
  • 2
    OPTN & SRTR Annual Data Report. 2010; Available at: Accessed December 3, 2012.
  • 3
    Opelz G, Döhler B. Association of HLA mismatch with death with a functioning graft after kidney transplantation: A Collaborative Transplant Study Report. Am J Transplant 2012; 12: 30313038.
  • 4
    ANZDATA. Accessed November 13, 2012.
  • 5
    Kahwaji J, Bunnapradist S, Hsu JW, Idroos ML, Dudek R. Cause of death with graft function among renal transplant recipients in an integrated healthcare system. Transplantation 2011; 91: 225230.
  • 6
    Boots JM, Christiaans MH, van Hooff JP. Effect of immunosuppressive agents on long-term survival of renal transplant recipients: Focus on the cardiovascular risk. Drugs 2004; 64: 20472073.
  • 7
    Poetker DM, Reh DD. A comprehensive review of the adverse effects of systemic corticosteroids. Otolaryngol Clin NY Am 2010; 43: 753768.
  • 8
    Knight SR, Morris PJ. Steroid avoidance or withdrawal after renal transplantation increases the risk of acute rejection but decreases cardiovascular risk. A meta-analysis. Transplantation 2010; 89: 114.
  • 9
    Vincenti F, Schena FP, Paraskevas S, et al. A randomized, multicenter study of steroid avoidance, early steroid withdrawal or standard steroid therapy in kidney transplant recipients. Am J Transplant 2008; 8: 307316.
  • 10
    Vanrenterghem Y, Lebranchu Y, Hené R, Oppenheimer F, Ekberg H. Double-blind comparison of two corticosteroid regimens plus mycophenolate mofetil and cyclosporine for prevention of acute renal allograft rejection. Transplantation 2000; 70: 13521359.
  • 11
    Woodle ES, Peddi VR, Tomlanovich S, Mulgaonkar S, Kuo PC, TRIMS Study Investigators. A prospective, randomized, multicenter study evaluating early corticosteroid withdrawal with Thymoglobulin in living-donor kidney transplantation. Clin Transplant 2010; 24: 7383.
  • 12
    Woodle ES, First MR, Pirsch J, et al. A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy. Ann Surg 2008; 248: 564577.
  • 13
    Nematalla AH, Bakr MA, Gheith OA, Elagroudy AE, Elshahawy el-M, Aghoneim M. Steroid-avoidance immunosuppression regimen in live-donor renal allotransplant recipients: A prospective, randomized, controlled study. Exp Clin Transplant 2007; 5: 673679.
  • 14
    Knight SR, Morris PJ. Interaction between maintenance steroid dose and the risk/benefit of steroid avoidance and withdrawal regimens following renal transplantation. Transplantation 2011; 92: e63e64.
  • 15
    Pascual J, Zamora J, Galeano C, Royuela A, Quereda C. Steroid avoidance or withdrawal for kidney transplant recipients. Cochrane Database Syst Rev 2009 (1): CD005632.
  • 16
    Cantarovich D, Rostaing L, Kamar N. et al. Corticosteroid avoidance in adult kidney transplant recipients under rabbit anti-T-lymphocyte globulin, mycophenolate mofetil and delayed cyclosporine microemulsion introduction. Transpl Int 2010; 23: 313324.
  • 17
    Vincenti F, Monaco A, Grinyo J, Kinkhabwala M, Roza A. Multicenter randomized prospective trial of steroid withdrawal in renal transplant recipients receiving basiliximab, cyclosporine microemulsion and mycophenolate mofetil. Am J Transplant 2003; 3: 306311.
  • 18
    ter Meulen CG, van Riemsdijk I, Hené RJ, et al. Steroid-withdrawal at 3 days after renal transplantation with anti-IL-2 receptor alpha therapy: A prospective, randomized, multicenter study. Am J Transplant 2004; 4: 803810.
  • 19
    Ahsan N, Hricik D, Matas A. et al. Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil—A prospective randomized study. Transplantation 1999; 68: 18651874.
  • 20
    Pascual J, Royuela A, Galeano C, Crespo M, Zamora J. Very early steroid withdrawal or complete avoidance for kidney transplant recipients: A systematic review. Nephrol Dial Transplant 2012; 27: 825832.
  • 21
    Opelz G, Döhler B, Laux G, for the Collaborative Transplant Study. Long-term prospective study of steroid withdrawal in kidney and heart transplant recipients. Am J Transplant 2005; 5: 720728.
  • 22
    Haynes RC, Murad F. Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. In: Goodman LS, Gilman A, Rall TW, Nies AS, Taylor P, eds. Goodman and Gilman's, The Pharmacological Basis of Therapeutics. 8th ed. New York: Macmillan Publishing Company, 1991; p. 1431.
  • 23
    Arns W, Breuer S, Choudhury S, et al. Enteric-coated mycophenolate sodium delivers bioequivalent MPA exposure compared with mycophenolate mofetil. Clin Transplant 2005; 19: 199206.
  • 24
    Opelz G, Wujciak T, Ritz E, for the Collaborative Transplant Study. Association of chronic kidney graft failure with recipient blood pressure. Kidney Int 1998; 53: 217222.
  • 25
    Weiner DE, Carpenter MA, Levey AS, et al. Kidney function and risk of cardiovascular disease and mortality in kidney transplant recipients: The FAVORIT trial. Am J Transplant 2012; 12: 24372445.